Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Magnificent Marvell Can Extend Bullishness in Second Half

BY | ETF Database
7:20 am ET 07/01/26 | 8 VIEWS
In the first half of this year, one of the obvious winners among large-cap technology stocks was Marvell Technology (MRVL). Coming off a 45% gain last month, the semiconductor stock is now up more than 250% year-to-date.That’s a massive move in a short timeframe, implying the stock and the Direxion Daily MRVL Bull 2X ETF (MRVU) may be due for breathers, but there are reasons to believe this high-flying tech name can extend its bullish ways in the second half of the year. If that outlook is validated, traders will have plenty of opportunities to embrace MRVU. This fund attempts to deliver 200% of the daily performance of the chip stock. To its credit, Marvell ended June on a strong note. MRVU pushed higher on the final trading day of the month. This was after UBS lifted its price target on the stock to $340 from $230. It cited potential for expanded revenue on the data center front.More Marvell CatalystsAmazon’s (AMZN) artificial intelligence (AI) semiconductor plans may also be indicative of MRVU opportunity. “The most likely driver is renewed enthusiasm around custom AI silicon after Amazon explored selling its Trainium chips to outside customers, which investors appear to view as a positive read-through for Marvell’s design and connectivity business,” according to Quiver Quantitative. “Marvell is deeply tied to hyperscale AI infrastructure, so any sign that the custom-chip market is expanding can lift expectations for future demand.” Prospective MRVU traders should monitor potential evolution in Marvell’s customer base. The company’s products are clearly in demand, but it remains highly dependent on a small number of customers. Any broadening of that client roll could be a second half catalyst for the stock and MRVU, assuming that situation materializes. “With three customers representing 75% of gross accounts receivable and a target to grow custom silicon revenue to over $10 billion by FY29, Marvell’s growth trajectory is tied to the strategic decisions of a handful of hyperscalers, creating massive upside if execution holds but existential risk if any major customer pivots to in-house solutions,” noted EveryTicker. Looking further, Marvell’s next quarterly earnings update is estimated to arrive on Aug. 27, providing opportunity for short-term traders to consider MRVU. One factor to watch for will be margin improvement comparable to or in excess of reporting in the first quarter. “Gross margin expanded 1.8 percentage points year-over-year to 51.5% (GAAP) and 58.25-59.25% on a non-GAAP basis. This improvement demonstrates pricing power in AI-related products and better cost absorption at higher volumes,” added EveryTicker. For more news, information, and analysis, visit the Leveraged & Inverse Content Hub.

More Commentary

June's Top ETFs: Biotech & China Semiconductors Surge
BY | ETF Database
9:08 am ET 07/01/26 | 2 VIEWS
Ward Off Inflation With This Bond ETF
BY | ETF Database
6:12 am ET 07/01/26 | 16 VIEWS
ETF Prime: Record Inflows and SpaceX Leveraged ETFs
BY | ETF Database
9:02 am ET 07/01/26 | 3 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.